Regarding worries that it might raise the risk of cancer, medicine maker Lupin Pharmaceuticals Inc. voluntarily recalled four lots of the blood pressure medication Quinapril last week, based on the Food and Drug Administration (FDA).
Quinapril tablets from Lupin Pharmaceuticals Inc., available in 20 mg and 40 mg strengths, may have a higher-than-acceptable daily consumption amount of the nitrosamine impurity N-Nitroso-Quinapril. The recall claims that nitrosamine impurities are frequently found in foods, such as grilled and smoked meats, vegetables, and dairy products.
According to the recall, “Everyone is exposed to a certain level of nitrosamines.” If people are exposed to these contaminants at amounts above what is considered safe for a long time, they may increase their risk of developing cancer.
Patients who are taking the medicine don’t have to stop taking it right now, but it is recommended that they speak with their doctor about a different course of action.
The affected lots have expiration dates that range from December 2022 to March 2024 and were issued from March 2021 to September 2022. The bottles had a 90-count capacity. The impacted lot numbers are listed here.
The drug’s production was discontinued in September, according to Lupin Pharmaceuticals Inc. The company also stated it was negotiating with suppliers to arrange for the return of the batches of recalled goods.